A detailed history of Us Bancorp \De\ transactions in Fibrogen Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 8,444 shares of FGEN stock, worth $4,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,444
Previous 10,044 15.93%
Holding current value
$4,053
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$0.33 - $1.26 $528 - $2,016
-1,600 Reduced 15.93%
8,444 $3,000
Q1 2024

May 07, 2024

SELL
$0.73 - $2.73 $651 - $2,435
-892 Reduced 8.16%
10,044 $23,000
Q4 2023

Feb 09, 2024

BUY
$0.38 - $0.91 $3,936 - $9,425
10,358 Added 1792.04%
10,936 $9,000
Q3 2023

Nov 03, 2023

SELL
$0.79 - $2.83 $60 - $215
-76 Reduced 11.62%
578 $0
Q2 2023

Aug 09, 2023

SELL
$2.49 - $20.59 $164 - $1,358
-66 Reduced 9.17%
654 $1,000
Q4 2022

Feb 13, 2023

SELL
$13.27 - $17.73 $5,122 - $6,843
-386 Reduced 34.9%
720 $11,000
Q3 2022

Oct 27, 2022

SELL
$11.4 - $14.6 $296 - $379
-26 Reduced 2.3%
1,106 $14,000
Q2 2022

Aug 01, 2022

SELL
$7.94 - $12.96 $1,492 - $2,436
-188 Reduced 14.24%
1,132 $12,000
Q1 2022

May 11, 2022

SELL
$12.02 - $16.79 $17,549 - $24,513
-1,460 Reduced 52.52%
1,320 $16,000
Q4 2021

Feb 11, 2022

SELL
$9.93 - $15.39 $2,264 - $3,508
-228 Reduced 7.58%
2,780 $40,000
Q3 2021

Nov 10, 2021

SELL
$10.18 - $26.64 $1,394 - $3,649
-137 Reduced 4.36%
3,008 $31,000
Q2 2021

Aug 05, 2021

SELL
$18.57 - $35.68 $193,833 - $372,427
-10,438 Reduced 76.85%
3,145 $84,000
Q1 2021

Apr 28, 2021

BUY
$31.0 - $55.72 $50,623 - $90,990
1,633 Added 13.67%
13,583 $472,000
Q4 2020

Feb 04, 2021

SELL
$37.09 - $48.97 $63,794 - $84,228
-1,720 Reduced 12.58%
11,950 $443,000
Q3 2020

Nov 10, 2020

BUY
$40.47 - $45.5 $349,094 - $392,483
8,626 Added 171.02%
13,670 $562,000
Q2 2020

Aug 07, 2020

BUY
$32.57 - $42.83 $15,894 - $20,901
488 Added 10.71%
5,044 $205,000
Q1 2020

May 13, 2020

BUY
$23.3 - $45.96 $105,828 - $208,750
4,542 Added 32442.86%
4,556 $158,000
Q4 2019

Feb 04, 2020

SELL
$34.58 - $48.06 $75,107 - $104,386
-2,172 Reduced 99.36%
14 $1,000
Q3 2019

Nov 08, 2019

BUY
$36.98 - $48.45 $517 - $678
14 Added 0.64%
2,186 $81,000
Q2 2019

Aug 13, 2019

BUY
$35.13 - $55.53 $33,830 - $53,475
963 Added 79.65%
2,172 $98,000
Q1 2019

May 08, 2019

BUY
$42.83 - $59.91 $40,859 - $57,154
954 Added 374.12%
1,209 $65,000
Q4 2018

Feb 13, 2019

SELL
$37.97 - $60.16 $8,125 - $12,874
-214 Reduced 45.63%
255 $12,000
Q3 2018

Nov 01, 2018

BUY
$56.3 - $67.25 $731 - $874
13 Added 2.85%
469 $29,000
Q2 2018

Aug 08, 2018

SELL
$44.9 - $64.95 $12,212 - $17,666
-272 Reduced 37.36%
456 $28,000
Q1 2018

May 08, 2018

BUY
$45.35 - $61.65 $4,897 - $6,658
108 Added 17.42%
728 $34,000
Q4 2017

Feb 02, 2018

BUY
$41.95 - $60.1 $8,138 - $11,659
194 Added 45.54%
620 $30,000
Q3 2017

Nov 13, 2017

BUY
$33.4 - $53.9 $14,228 - $22,961
426
426 $23,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $45M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.